netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Dabigatran found 10 matches

Open monograph to display formulary status BNF Category
  Dabigatran Cardiovascular system - Oral anticoagulants - 02.08.02
  Idarucizumab Cardiovascular system - Anticoagulants and protamine - 02.08
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update Dec 2014: Dabigatran (Pradaxa): contraindicated in patients with prosthetic heart valve(s) requiring anti-coagulant treatment (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section NICE TA157: Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults (02.08.02)
link in drug section NICE TA249: Dabigatran for Stroke prevention in AF (02.08.02)
link in drug section NICE TA327: Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (02.08.02)


 

netFormulary